Welcome to our dedicated page for Vital Farms SEC filings (Ticker: VITL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Vital Farms, Inc. (Nasdaq: VITL) is a Certified B Corporation and Delaware public benefit corporation that focuses on pasture-raised eggs and egg-based foods such as shell eggs, butter, hard-boiled eggs, and liquid whole eggs. As a publicly traded company, Vital Farms files regular reports and current reports with the U.S. Securities and Exchange Commission (SEC), providing detailed information on its financial performance, risks, governance, and strategic initiatives.
On this page, you can review Vital Farms’ SEC filings, including annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe its business model, farm network, product categories, and risk factors related to supply, consumer demand, agricultural disease, regulation, and macroeconomic conditions. These filings also discuss its status as a public benefit corporation, its stakeholder-focused objectives, and its emphasis on humane treatment of farm animals and sustainable farming practices.
Current reports on Form 8-K offer more immediate updates. Recent 8-K filings have covered quarterly financial results, long-term net revenue targets, and governance matters such as the appointment of a new independent director and the frequency of advisory Say-on-Pay votes. An amended 8-K explains the company’s decision to hold non-binding advisory votes on executive compensation annually, following stockholder preferences.
Stock Titan’s platform enhances access to these documents with AI-powered summaries that explain key sections of Vital Farms’ filings in plain language. Investors can quickly understand highlights from lengthy 10-K and 10-Q reports, see what management disclosed in 8-K earnings releases, and track governance items without reading every page. Real-time updates from EDGAR ensure that new filings appear promptly, while AI-generated overviews help readers identify significant changes, recurring themes, and references to long-term targets and capital projects.
For users monitoring insider and governance activity, this page also centralizes access to forms and disclosures related to directors and executive compensation policies as referenced in Vital Farms’ filings.
Insider sale notice for VITL: This Form 144 shows proposed sale of 100,000 common shares on or about 09/02/2025 through Morgan Stanley Smith Barney (NASDAQ). The filer acquired the shares as founder stock on 01/06/2015 and paid cash. The issuer has 44,685,980 shares outstanding, making the proposed block ~0.22% of outstanding shares. The filing also lists prior sales by the same person totaling 210,000 shares between 06/13/2025 and 08/29/2025, with gross proceeds reported for each trade. The notice includes the standard representation that the seller is not aware of any undisclosed material adverse information about the issuer.
Vital Farms insider sale notice. This Form 144 shows that Matthew O'Hayer, identified as the person for whose account the securities are to be sold, intends to sell 100,000 common shares through Morgan Stanley Smith Barney LLC on or about 08/29/2025 on NASDAQ. The shares were acquired as founder stock on 01/06/2015 and payment was in cash. The filing also lists multiple recent sales by the same person during June–August 2025 totaling 110,000 shares, with individual gross proceeds reported for each trade. The filing includes a standard representation that the seller is not aware of undisclosed material adverse information.
Vital Farms insider sale reported on Form 4. Joanne Bal, listed as General Counsel, Secretary and Head of Impact and an officer of Vital Farms, sold 4,796 shares of Common Stock on 08/22/2025 at a price of $50.95 per share. Following the sale, the filing reports 43,332 shares beneficially owned. The Form 4 was signed by an attorney-in-fact on 08/26/2025.
Matthew Ohayer, Executive Chairperson, Director and 10% owner of Vital Farms, Inc. (VITL) reported a sale of 4,200 shares of common stock on 08/21/2025 at $50.25 per share executed under a Rule 10b5-1 trading plan adopted March 14, 2025. Following the reported sale, Mr. Ohayer directly beneficially owns 6,827,070 shares. He is also recorded as having 716,000 shares of indirect beneficial ownership held by a former spouse, over which he has sole voting control but no pecuniary interest per the filing. The Form 4 was signed by an attorney-in-fact on 08/25/2025.
This Form 144 filed for Vital Farms, Inc. (VITL) reports a proposed sale of 4,796 common shares through Morgan Stanley Smith Barney LLC on 08/22/2025 with an aggregate market value of $244,347.09. The filing lists prior sales by the same person, JOANNE BAL, of 9,609 and 390 common shares on 08/15/2025 generating gross proceeds of $458,344.50 and $18,602.81, respectively. Acquisition details show the shares to be sold were received as restricted stock vesting under a registered plan on 03/10/2023 (42 shares), 03/13/2024 (3,294 shares), and 04/26/2024 (1,460 shares). The filer certifies no undisclosed material adverse information is known.
Vital Farms insider sale: Executive Chairperson and director Matthew Ohayer sold 800 shares on 08/19/2025 under a pre-established Rule 10b5-1 plan. The reported weighted-average sale price was $50.31, with individual trade prices ranging from $50.27 to $50.35. After the disposition the filing shows Mr. Ohayer directly beneficially owns 6,831,270 shares and is reported as the indirect beneficial owner of 716,000 shares held by his former spouse, over which he has sole voting control but no pecuniary interest. The Form 4 was signed by an attorney-in-fact on 08/21/2025 and discloses the plan adoption date of March 14, 2025.
Kathryn McKeon, CMO and GM, Butter at Vital Farms (VITL), reported scheduled insider transactions in August 2025. On 08/15/2025 she sold 12,005 shares under a Rule 10b5-1 plan at a weighted average price of $47.59, reducing her beneficial holdings to 37,513 shares. On 08/18/2025 she exercised and acquired 21,442 shares under an employee stock option with a $15.31 exercise price and simultaneously sold 21,442 shares at a weighted average price of $49.08. After these transactions she beneficially owns 58,955 shares (direct). The Form 4 discloses the 10b5-1 plan was adopted on May 16, 2025, and the option vests in three equal annual installments starting 03/13/2024.
Vital Farms officer Joanne Bal reported the sale of 9,999 shares of the company's common stock on 08/15/2025 at a weighted average price of $47.70 per share, with transaction prices ranging from $47.60 to $47.81. After the sale, the reporting person beneficially owned 48,128 shares, a total that includes 229 shares acquired under the company's Employee Stock Purchase Plan on 05/15/2025. The Form 4 was signed by an attorney-in-fact on 08/19/2025. The filing identifies the reporting person as an officer with the title GC, SEC. AND HEAD OF IMPACT.
Form 144 for Vital Farms, Inc. (VITL) shows a proposed sale of 21,442 common shares valued at $1,023,855.50 to be executed on 08/18/2025 on NASDAQ through Morgan Stanley Smith Barney LLC. The filing states these shares were acquired the same day by exercise of stock options from the issuer and paid in cash. The filer also reported recent 10b5-1 sales on 08/15/2025 of 12,005 shares generating $571,346.76. The filing includes an assurance that the signer does not possess undisclosed material adverse information.
Vital Farms insider sale by Director Denny Marie Post — On 08/14/2025 the reporting person sold 6,086 shares of Vital Farms, Inc. (VITL) common stock at a weighted average price of $47.75 per share. After the reported disposition the reporting person beneficially owned 16,312 shares. The filing notes the sale occurred in multiple transactions at prices ranging from $47.74 to $47.81 and that the signer, an attorney-in-fact, executed the Form 4 on behalf of the reporting person.
FAQ
What is the current stock price of Vital Farms (VITL)?
What is the market cap of Vital Farms (VITL)?
